Related Experiment Video
Updated: Feb 18, 2026
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Pediatric Multiple Sclerosis: From Recognition to Practical Clinical Management
Cynthia X Wang1, Benjamin M Greenberg1
1Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8806, USA.
Insights
Pediatric multiple sclerosis (MS) parallels adult MS but presents unique challenges. Early risk factor exposure and developmental considerations complicate diagnosis and treatment for children with this rare neurologic disease.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Pediatric multiple sclerosis (MS) is a rare neurological disorder.
- MS pathogenesis risk factors may be encountered in childhood.
- Pediatric MS presents unique diagnostic and therapeutic challenges compared to adult-onset MS.
Purpose of the Study:
- To highlight the parallels and divergences of pediatric MS from adult MS.
- To discuss the complexities in diagnosing MS in children.
- To address the challenges in managing pediatric MS with disease-modifying therapies.
Main Methods:
- Review of existing literature on pediatric multiple sclerosis.
- Analysis of diagnostic criteria and differential diagnoses for pediatric MS.
- Examination of current therapeutic approaches and research gaps for pediatric MS.
Main Results:
- Pediatric MS shares similarities with adult MS but has distinct features.
- Diagnosis can be difficult due to atypical presentations in children.
- Limited rigorous studies exist for disease-modifying therapies in pediatric MS.
Conclusions:
- Pediatric MS requires specialized diagnostic and management strategies.
- Further research is crucial for understanding MS pathogenesis in developing systems.
- Developing safe and effective treatments for pediatric MS is a critical unmet need.
Abstract:
Pediatric-onset multiple sclerosis (MS) is a rare but increasingly recognized condition that both parallels and diverges from adult-onset MS. Exposure to key risk determinants for MS disease pathogenesis may occur during childhood. The diagnosis of pediatric MS can be challenging due to potential for atypical presentations and a broad differential diagnosis. MS disease-modifying therapies have not been rigorously studied in children and raise difficult questions on how to manage a chronic inflammatory neurologic disease in a population of patients with developing central nervous and immune systems.
Related Concept Videos
01:15Parkinson's Disease: Overview
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...